Overall, these results strongly support a similar role for K2P18.1 in the regulation of tTreg development and autoimmunity in humans, further underlining the clinical relevance of our findings and opening up the possibility to exploit this mechanism in therapeutic applications. The gene discussed is KCNK18; the disease is Autoimmunity.